Differences in proportion adjuvant chemotherapy are not associated with relative survival for stage II colon cancer patients aged 75 years and older - a EURECCA international comparison

被引：0

作者：

Breugom, A. J. ^{[1
]}

Bastiaannet, E. ^{[1
]}

Boelens, P. G. ^{[1
]}

Van Eycken, E. ^{[2
]}

Vandendael, T. ^{[2
]}

Iversen, L. H. ^{[3
]}

O'Brien, K. ^{[4
]}

Martling, A. ^{[5
]}

Pahlman, L. ^{[6
]}

Liefers, G. J. ^{[1
]}

Rutten, H. J. T. ^{[7
]}

Lemmens, V. E. ^{[8
]}

Van de Velde, C. J. H. ^{[1
]}

机构：

[1] Leiden Univ, Med Ctr, Surg, Leiden, Netherlands

[2] Belgian Canc Registry, Res, Brussels, Belgium

[3] Aarhus Univ Hosp, Surg, DK-8000 Aarhus, Denmark

[4] Natl Canc Registry Ireland, Res, Cork, Ireland

[5] Karolinska Inst, Moleculare Med & Surg, Stockholm, Sweden

[6] Uppsala Univ, Surg Sci, Uppsala, Sweden

[7] Catharina Hosp, Surg, Eindhoven, Netherlands

[8] Comprehens Canc Ctr Netherlands, Res, Utrecht, Netherlands

来源：

EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷

关键词：

D O I：

10.1016/S0959-8049(16)30566-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1323

引用

页码：S195 / S195

页数：1

共 50 条

[41] PREDICTORS OF COMPLIANCE AND SURVIVAL WITH ADJUVANT CHEMOTHERAPY IN OLDER ADULTS WITH STAGE III COLON CANCER.
Simon, H.
de Paula, T. Reif
Spigel, Z.
Keller, D.
[J]. DISEASES OF THE COLON & RECTUM, 2022, 65 (05) : 36 - 36
[42] Adjuvant Chemotherapy Benefit in Elderly Stage II/III Colon Cancer Patients
Chen, Xin
Tu, Junhao
Xu, Xiaolan
Gu, Wen
Qin, Lei
Qian, Haixin
Jia, Zhenyu
Ma, Chuntao
Xu, Yinkai
[J]. FRONTIERS IN ONCOLOGY, 2022, 12
[43] The impact of adjuvant chemotherapy regimens in stage II colon cancer (CC) patients
Lobo-Martins, S.
Martins, M.
Semedo, P.
Alvim, C.
Luna Pais, H.
Paiva, R.
Pinto, C.
Ribeiro, L.
Fernandes, I.
Macedo, D.
Mansinho, A.
Vendrell, I.
Teixeira de Sousa, R.
Costa, L.
[J]. ANNALS OF ONCOLOGY, 2020, 31 : S139 - S139
[44] EURECCA international comparison of treatment and survival in metastatic rectal cancer for patients over the age of 80 years
Bastiaannet, E.
Breugom, A.
Kiderlen, M.
Iversen, L.
Martling, A.
Johansson, R.
Ortiz, H.
Valentini, V.
Van Eycken, E.
Vandendael, T.
Mroczkowski, P.
Lippert, H.
Rutten, H.
Liefers, G. J.
Lemmens, V.
Boelens, P.
Van de Velde, C.
[J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S195 - S195
[45] Early Postoperative Mortality Among Patients Aged 75 Years or Older With Stage II/III Rectal Cancer
Sineshaw, Helmneh M.
Yabroff, K. Robin
Tsikitis, V. Liana
Jemal, Ahmedin
Mitin, Timur
[J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (04): : 443 - +
[46] Adjuvant Chemotherapy Use Among Older Patients With Stage III Colon Cancer Reply
Kahn, Katherine L.
Fletcher, Robert H.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 303 (23): : 2353 - 2354
[47] Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An Underused Lifesaving Treatment
Muss, Hyman B.
Bynum, Debra L.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (21) : 2576 - 2578
[48] Administration of adjuvant chemotherapy in older patients with Stage III colon cancer: an observational study
van den Broek, C. B. M.
Puylaert, C. C. E. M.
Breugom, A. J.
Bastiaannet, E.
de Craen, A. J. M.
van de Velde, C. J. H.
Liefers, G. -J.
Portielje, J. E. A.
[J]. COLORECTAL DISEASE, 2017, 19 (10) : O358 - O364
[49] Comparing treatment strategies and relative survival between the Netherlands and Belgium for patients aged 75 years and older with stage I-III rectal cancer
Breugom, A. J.
Bastiaannet, E.
Boelens, P. G.
Van Eycken, E.
Vandendael, T.
Liefers, G. J.
Rutten, H. J. T.
Lemmens, V. E.
Van de Velde, C. J. H.
[J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S371 - S371
[50] Neutropenia and Relative Dose Intensity on Adjuvant FOLFOX Chemotherapy Are Not Associated with Survival for Resected Colon Cancer
Smoragiewicz M.
Javaheri K.R.
Yin Y.
Gill S.
[J]. Journal of Gastrointestinal Cancer, 2014, 45 (4) : 460 - 465

← 1 2 3 4 5 →